1.

La sitagliptine dans le traitement du diabete de type 2: le point, cinq ans apres sa commercialisation. ; Sitagliptin in the treatment of type 2 diabetes: insights five years after...

1.

The impact of reimbursement criteria on the appropriateness of 'statin' prescribing.

1.

Data_Sheet_1_An Innovative Approach for Decision-Making on Designing Lifestyle Programs to Reduce Type 2 Diabetes on Dutch Population Level Using Dynamic Simulations.docx

2.

Data_Sheet_1_An Innovative Approach for Decision-Making on Designing Lifestyle Programs to Reduce Type 2 Diabetes on Dutch Population Level Using Dynamic Simulations.docx

3.

Data_Sheet_1_An Innovative Approach for Decision-Making on Designing Lifestyle Programs to Reduce Type 2 Diabetes on Dutch Population Level Using Dynamic Simulations.docx

1.

Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases:a randomized controlled trial

2.

Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases:a randomized controlled trial

3.

Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases:a randomized controlled trial

1.

Associations between periconceptional lifestyle behaviours and adverse pregnancy outcomes

1.

The STIB score: a simple clinical test to predict clopidogrel resistance.

2.

The STIB score: a simple clinical test to predict clopidogrel resistance.

3.

The STIB score: a simple clinical test to predict clopidogrel resistance.

1.

L'etude clinique du mois. NAVIGATOR: essai de prevention des complications cardio-vasculaires et du diabete de type 2 par le valsartan et/ou le nateglinide. ; NAVIGATOR: A trial of...

1.

RESPECT-study questionnaire—First visit (original Dutch version).